4//SEC Filing
Koneru Mythili 4
Accession 0001209191-20-018535
CIK 0001094038other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 4:40 PM ET
Size
8.3 KB
Accession
0001209191-20-018535
Insider Transaction Report
Form 4
Koneru Mythili
Snr VP, Clinical Development
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-03-10+116,100→ 116,100 totalExercise: $2.12Exp: 2030-03-10→ Common Stock (116,100 underlying) - Award
Employee Stock Option (Right to Buy)
2020-03-10+23,900→ 23,900 totalExercise: $2.12Exp: 2030-03-10→ Common Stock (23,900 underlying)
Footnotes (2)
- [F1]Represents a bonus for 2019 performance granted under the Company's 2014 Omnibus Stock Ownership Plan. This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.
- [F2]This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.
Documents
Issuer
Marker Therapeutics, Inc.
CIK 0001094038
Entity typeother
Related Parties
1- filerCIK 0001776659
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 4:40 PM ET
- Size
- 8.3 KB